Back to search
Plasma Cell Dyscrasias
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Plasma Cell Dyscrasias trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Plasma Cell Dyscrasias trials you may qualify forThe iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimens…
The purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which su…
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignan…
The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have crea…
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has…
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
AL (or light chain) amyloidosis begins in the bone marrow where abnormal proteins misfold and create free light chains that cannot be broken down. These free li…
AL (or light chain) amyloidosis begins in the bone marrow where abnormal proteins misfold and create free light chains that cannot be broken down. These free li…